1.Oculogyric Crisis Due to Metronidazole Toxic Encephalopathy
Sang Woo LEE ; Hyeongseok KIM ; Deokhyun HEO ; Jeong Ho PARK
Journal of the Korean Neurological Association 2018;36(4):322-324
Oculogyric crisis is an acute dystonia involving ocular muscles characterized by sustained conjugate upward or lateral deviation of the eyes. Metronidazole is a commonly used antimicrobial agent in treatment of anaerobic infections. However, its long-term use can cause toxic encephalopathy particularly in patients with hepatic dysfunction. Here, we describe a case of oculogyric crisis as a presenting manifestation of metronidazole-induced encephalopathy.
Brain Diseases
;
Dystonia
;
Humans
;
Metronidazole
;
Muscles
;
Neurotoxicity Syndromes
2.Regulation of Osteoclast Differentiation by Cytokine Networks
Dulshara Sachini AMARASEKARA ; Hyeongseok YUN ; Sumi KIM ; Nari LEE ; Hyunjong KIM ; Jaerang RHO
Immune Network 2018;18(1):e8-
Cytokines play a pivotal role in maintaining bone homeostasis. Osteoclasts (OCs), the sole bone resorbing cells, are regulated by numerous cytokines. Macrophage colony-stimulating factor and receptor activator of NF-κB ligand play a central role in OC differentiation, which is also termed osteoclastogenesis. Osteoclastogenic cytokines, including tumor necrosis factor-α, IL-1, IL-6, IL-7, IL-8, IL-11, IL-15, IL-17, IL-23, and IL-34, promote OC differentiation, whereas anti-osteoclastogenic cytokines, including interferon (IFN)-α, IFN-β, IFN-γ, IL-3, IL-4, IL-10, IL-12, IL-27, and IL-33, downregulate OC differentiation. Therefore, dynamic regulation of osteoclastogenic and anti-osteoclastogenic cytokines is important in maintaining the balance between bone-resorbing OCs and bone-forming osteoblasts (OBs), which eventually affects bone integrity. This review outlines the osteoclastogenic and anti-osteoclastogenic properties of cytokines with regard to osteoimmunology, and summarizes our current understanding of the roles these cytokines play in osteoclastogenesis.
Cytokines
;
Homeostasis
;
Interferons
;
Interleukin-1
;
Interleukin-10
;
Interleukin-11
;
Interleukin-12
;
Interleukin-15
;
Interleukin-17
;
Interleukin-23
;
Interleukin-27
;
Interleukin-3
;
Interleukin-33
;
Interleukin-4
;
Interleukin-6
;
Interleukin-7
;
Interleukin-8
;
Macrophage Colony-Stimulating Factor
;
Necrosis
;
Osteoblasts
;
Osteoclasts
;
RANK Ligand
3.Cerebral Coenurosis of a Long-Tailed Goral, Naemorhedus caudatus, in Korea
Sangjin AHN ; Hyeongseok OH ; Soo-Young CHOI ; Jong-Taek KIM ; Hyeon-Cheol KIM
The Korean Journal of Parasitology 2021;59(1):55-59
We intended to describe a case of cerebral coenurosis in a long-tailed goral, Naemorhedus caudatus, from Hwacheon-gun, Gangwon-do (Province), in the Korea. The goral, a 10-year-old male, was suffering from neurological symptoms, such as turning the circle to one side without lifting the head straight, and died at 30 days after admission to the wildlife medical rescue center in Chuncheon-si, Gangwon-do. A fluid-filled cyst was detected in the left cerebral hemisphere by computed tomography and magnetic resonance imaging. The cyst removed from the deceased goral was transparent, about 3×3 cm in size, contained a clear fluid and approximately 320 protoscolices invaginating from the internal germinal layer. The protoscolex had 4 suckers and a rostellum with 28 hooklets arranged in 2 rows. By the present study, a case of cerebral coenurosis was first confirmed in a long-tailed goral, N. caudatus, from Gangwon-do, in Korea. The residents frequently exposed in the sylvatic environment should be careful the accidental infections of zoonotic metacestode of Taenia multiceps, Coenurus cerebralis, in Korea.
4.Osteogenic Differentiation of Bone Marrow Stem Cell in Poly(Lactic-co-Glycolic Acid) Scaffold Loaded Various Ratio of Hydroxyapatite.
Hyeongseok KIM ; Hye Min KIM ; Ji Eun JANG ; Cho Min KIM ; Eun Young KIM ; Dongwon LEE ; Gilson KHANG
International Journal of Stem Cells 2013;6(1):67-74
BACKGROUND AND OBJECTIVES: Hydroxyapatite has biocompatibility and bioactivity and similar to bone of in human body. The purpose of this study is to evaluate osteogenic differentiation of bone marrow stem cell (BMSC) in PLGA Scaffold added various ratio of hydroxyapatite (HAp). METHODS AND RESULTS: PLGA and PLGA/HAp scaffold were prepared using solvent casting/salt-leaching method. BMSC was seeded on the PLGA and PLGA/HAp scaffold and the samples were cultured in 37degrees C incubator with 5% CO2 for 28 days. Alkaline phosphatase (ALP) was carried out to evaluate alkaline phosphatase activity at 1, 3, 7, 10 and 14 days. Alizarin Red S stating was performed to identify calcium in scaffold at 1, 7, 14, 21 and 28 days. Compressive strength was measured to evaluate mechanical property of scaffold. To confirm cell viability, MTT was carried out at 1, 3, 7, 14 and 28 days. RT-PCR was performed to verify specific marker expression of osteoblast and stem cell at 7, 14, 21 and 28 days. CONCLUSIONS: Osteogenic differentiation of BMSC was confirmed through ALP, RT-PCR, and alizarin red S staining in this study. These results suggest that HAp helps osteogenic differentiation of BMSC.
Alkaline Phosphatase
;
Anthraquinones
;
Bone Marrow
;
Calcium
;
Cell Survival
;
Compressive Strength
;
Durapatite
;
Human Body
;
Incubators
;
Lactic Acid
;
Osteoblasts
;
Polyglycolic Acid
;
Seeds
;
Stem Cells
5.Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas
Jae Seung KANG ; Taesung PARK ; Youngmin HAN ; Seungyeon LEE ; Heeju LIM ; Hyeongseok KIM ; Se Hyung KIM ; Wooil KWON ; Sun Whe KIM ; Jin Young JANG
Annals of Surgical Treatment and Research 2019;97(2):58-64
PURPOSE: The 2017 international consensus guidelines (ICG) for intraductal papillary mucinous neoplasm (IPMN) of the pancreas were recently released. Important changes included the addition of worrisome features such as elevated serum CA 19-9 and rapid cyst growth (>5 mm over 2 years). We aimed to clinically validate the 2017 ICG and compare the diagnostic performance between the 2017 and 2012 ICG. METHODS: This was a retrospective cohort study. During January 2000–January 2017, patients who underwent complete surgical resection and had pathologic confirmation of branch-duct or mixed-type IPMN were included. To evaluate diagnostic performance, the areas under the receiver operating curves (AUCs) were evaluated. RESULTS: A total of 448 patients were included. The presence of mural nodule (hazard ratio [HR], 9.12; 95% confidence interval [CI], 4.60–18.09; P = 0.001), main pancreatic duct dilatation (>5 mm) (HR, 5.32; 95% CI, 2.67–10.60; P = 0.001), thickened cystic wall (HR, 3.40; 95% CI, 1.51–7.63; P = 0.003), and elevated CA 19-9 level (>37 unit/mL) (HR, 5.25; 95% CI, 2.05–13.42; P = 0.001) were significantly associated with malignant IPMN. Malignant lesions showed a cyst growth rate >5 mm over 2 years more frequently than benign lesions (60.9% vs. 29.7%, P = 0.012). The AUC was higher for the 2017 ICG than the 2012 ICG (0.784 vs. 0.746). CONCLUSION: The new 2017 ICG for IPMN is clinically valid, with a superior diagnostic performance to the 2012 ICG. The inclusion of elevated serum CA 19-9 level and cyst growth rate to the 2017 ICG is appropriate.
Area Under Curve
;
Carcinoma, Pancreatic Ductal
;
Cohort Studies
;
Consensus
;
Dilatation
;
Humans
;
Mucins
;
Pancreas
;
Pancreatic Ducts
;
Retrospective Studies
6.Essential Role of Protein Arginine Methyltransferase 1 in Pancreas Development by Regulating Protein Stability of Neurogenin 3
Kanghoon LEE ; Hyunki KIM ; Joonyub LEE ; Chang Myung OH ; Heein SONG ; Hyeongseok KIM ; Seung Hoi KOO ; Junguee LEE ; Ajin LIM ; Hail KIM
Diabetes & Metabolism Journal 2019;43(5):649-658
BACKGROUND: Protein arginine methyltransferase 1 (PRMT1) is a major enzyme responsible for the formation of methylarginine in mammalian cells. Recent studies have revealed that PRMT1 plays important roles in the development of various tissues. However, its role in pancreas development has not yet been elucidated. METHODS: Pancreatic progenitor cell-specific Prmt1 knock-out (Prmt1 PKO) mice were generated and characterized for their metabolic and histological phenotypes and their levels of Neurog3 gene expression and neurogenin 3 (NGN3) protein expression. Protein degradation assays were performed in mPAC cells. RESULTS: Prmt1 PKO mice showed growth retardation and a severely diabetic phenotype. The pancreatic size and β-cell mass were significantly reduced in Prmt1 PKO mice. Proliferation of progenitor cells during the secondary transition was decreased and endocrine cell differentiation was impaired. These defects in pancreas development could be attributed to the sustained expression of NGN3 in progenitor cells. Protein degradation assays in mPAC cells revealed that PRMT1 was required for the rapid degradation of NGN3. CONCLUSION: PRMT1 critically contributes to pancreas development by destabilizing the NGN3 protein.
Animals
;
Diabetes Mellitus
;
Endocrine Cells
;
Gene Expression
;
Islets of Langerhans
;
Mice
;
Pancreas
;
Phenotype
;
Protein Stability
;
Protein-Arginine N-Methyltransferases
;
Proteolysis
;
Stem Cells
7.Generation of an osteoblast-based artificial niche that supports in vitro B lymphopoiesis.
Jiyeon YU ; Seunga CHOI ; Hyeonkyeong KIM ; Nari LEE ; Hyeongseok YUN ; Sumi KIM ; Seong Tae JEONG ; Jaerang RHO
Experimental & Molecular Medicine 2017;49(11):e400-
B lymphocytes are produced from hematopoietic stem cells (HSCs) through the highly ordered process of B lymphopoiesis, which is regulated by a complex network of cytokines, chemokines and cell adhesion molecules derived from the hematopoietic niche. Primary osteoblasts function as an osteoblastic niche (OBN) that supports in vitro B lymphopoiesis. However, there are significant limitations to the use of primary osteoblasts, including their relative scarcity and the consistency and efficiency of the limited purification and proliferation of these cells. Thus, development of a stable osteoblast cell line that can function as a biomimetic or artificial OBN is necessary. In this study, we developed a stable osteoblastic cell line, designated OBN4, which functions as an osteoblast-based artificial niche that supports in vitro B lymphopoiesis. We demonstrated that the production of a B220⁺ cell population from Lineage⁻ (Lin⁻) Sca-1⁺ c-Kit⁺ hematopoietic stem and progenitor cells (HSPCs) was increased ~1.7-fold by OBN4 cells relative to production by primary osteoblasts and OP9 cells in coculture experiments. Consistently, OBN4 cells exhibited the highest production of B220⁺ IgM⁺ cell populations (6.7±0.6–13.6±0.6%) in an IL-7- and stromal cell-derived factor 1-dependent manner, with higher production than primary osteoblasts (3.7±0.5–6.4±0.6%) and OP9 cells (1.8±0.6–3.9±0.5%). In addition, the production of B220⁺ IgM⁺ IgD⁺ cell populations was significantly enhanced by OBN4 cells (15.4±1.1–18.9±3.2%) relative to production by primary osteoblasts (9.5±0.6–14.6±1.6%) and OP9 cells (9.1±0.5–10.3±1.8%). We conclude that OBN4 cells support in vitro B lymphopoiesis of Lin⁻ Sca-1⁺ c-Kit⁺ HSPCs more efficiently than primary osteoblasts or OP9 stromal cells.
B-Lymphocytes
;
Biomimetics
;
Cell Adhesion Molecules
;
Cell Line
;
Chemokines
;
Coculture Techniques
;
Cytokines
;
Hematopoietic Stem Cells
;
In Vitro Techniques*
;
Lymphopoiesis*
;
Osteoblasts
;
Stem Cells
;
Stromal Cells
8.Inhibition of Serotonin Synthesis Induces Negative Hepatic Lipid Balance.
Jun NAMKUNG ; Ko Eun SHONG ; Hyeongseok KIM ; Chang Myung OH ; Sangkyu PARK ; Hail KIM
Diabetes & Metabolism Journal 2018;42(3):233-243
BACKGROUND: Hepatic steatosis is caused by metabolic stress associated with a positive lipid balance, such as insulin resistance and obesity. Previously we have shown the anti-obesity effects of inhibiting serotonin synthesis, which eventually improved insulin sensitivity and hepatic steatosis. However, it is not clear whether serotonin has direct effect on hepatic lipid accumulation. Here, we showed the possibility of direct action of serotonin on hepatic steatosis. METHODS: Mice were treated with para-chlorophenylalanine (PCPA) or LP-533401 to inhibit serotonin synthesis and fed with high fat diet (HFD) or high carbohydrate diet (HCD) to induce hepatic steatosis. Hepatic triglyceride content and gene expression profiles were analyzed. RESULTS: Pharmacological and genetic inhibition of serotonin synthesis reduced HFD-induced hepatic lipid accumulation. Furthermore, short-term PCPA treatment prevented HCD-induced hepatic steatosis without affecting glucose tolerance and browning of subcutaneous adipose tissue. Gene expression analysis revealed that the expressions of genes involved in de novo lipogenesis and triacylglycerol synthesis were downregulated by short-term PCPA treatment as well as long-term PCPA treatment. CONCLUSION: Short-term inhibition of serotonin synthesis prevented hepatic lipid accumulation without affecting systemic insulin sensitivity and energy expenditure, suggesting the direct steatogenic effect of serotonin in liver.
Animals
;
Diabetes Mellitus
;
Diet
;
Diet, High-Fat
;
Energy Metabolism
;
Fatty Liver
;
Fenclonine
;
Gene Expression
;
Glucose
;
Insulin Resistance
;
Lipogenesis
;
Liver
;
Mice
;
Obesity
;
Serotonin*
;
Stress, Physiological
;
Subcutaneous Fat
;
Transcriptome
;
Triglycerides
9.The Study of Voice in Postmenopausal Syndrome.
Sang Hyun KIM ; Ho Sang NO ; Dong Jo HWANG ; Young Suk OH ; Sung Wook MOON ; Hyeongseok KIM ; Eui Sik JUNG ; Min Seok KOH
Korean Journal of Otolaryngology - Head and Neck Surgery 2000;43(10):1122-1125
OBJECTIVES: We intended to evaluate the relationship between voice and the menopause, so we observed vocal symptoms and voice parameters in patients of postmenopausal syndrome compared with those in premenopausal women. MATERIALS AND METHODS: Forty postmenopausal and twenty premenopausal women were included in this study. Each woman was asked to describe their subjective vocal symptoms and phonate a vowel /a/ sound for 3 seconds. The voices were recorded and analyzed by the Multi-Dimensional Voice Program and a Laryngograph. A statistical analysis of voice parameters was done by a paired-t-test. RESULTS: Vocal symptoms detected in the menopausal women were lowered pitch, voice fatigue, recurrent hoarseness, and loss of high tone. Jitter in postmenopausal group was significantly increased compared with the premenopausal group, but the fundamental frequency, shimmer, the Harmonics-to-noise ratio and the closing quotient showed no significant differences. There were no significant changes of voice parameters between menopausal patients with and without vocal symptoms. CONCLUSION: The change of voice may be objectively identified in postmenopausal women. In treating the postmenopausal symptoms, it may be required to take voice changes into consideration.
Female
;
Hoarseness
;
Humans
;
Menopause
;
Voice Disorders
;
Voice*
10.Experimental and Mathematical Optimization of a Pooling Test for Detection of SARS-CoV-2 in a Population with Low Viral Load
Hyeongseok JEONG ; Jooyeon LEE ; Shinhye CHEON ; Kyung Mok SOHN ; Jungok KIM ; Sungmin KYM ; Yeon-Sook KIM
Infection and Chemotherapy 2021;53(1):118-127
Background:
A pooling test is a useful tool for mass screening of coronavirus disease 2019 (COVID-19) in the pandemic era. We aimed to optimize a simple two-step pooling test by estimating the optimal pool size using experimental and mathematical validation.
Materials and Methods:
Experimental pools were created by mixing one positive respiratory sample with various numbers of negative samples. We selected positive samples with cycle threshold (Ct) values greater than 32 to validate the efficiency of the pooling test assuming a high likelihood of false-negative results due to low viral loads. The positivities of the experimental pools were investigated with a single reverse-transcription polymerase chain reaction (RT-PCR) using the U-TOP™ COVID-19 Detection Kit Plus (Seasun Biomaterials, Daejeon, Korea). We used the Dorfman equation to calculate the optimal size of a pooling test mathematically.
Results:
Viral RNA could be detected in a pool with a size up to 11, even if the Ct value of a positive sample was about 35. The Dorfman equation showed that the optimal number of samples in a pool was 11 when the prevalence was assumed to be 0.66% based on the test positivity in Daejeon, Korea from April 1, 2020 to November 10, 2020. The efficiency of the pooling test was 6.2, which can save 83.9 of 100 individual tests.
Conclusion
Eleven samples in a pool were validated optimal experimentally assuming a prevalence of 0.66%. The pool size needs modification as the pandemic progresses; thus, the prevalence should be carefully estimated before pooling tests are conducted.